Literature DB >> 12379177

2-Aminoethoxydiphenyl borate inhibits inositol 1,4,5-trisphosphate receptor function, ubiquitination and downregulation, but acts with variable characteristics in different cell types.

M D Soulsby1, R J H Wojcikiewicz.   

Abstract

2-Aminoethoxydiphenyl borate (2-APB) is a putative, membrane-permeable inhibitor of inositol 1,4,5-trisphosphate (InsP(3)) receptors, but it is the case that little is known about its action at the InsP(3) receptor level. Thus, we examined the effects of 2-APB on InsP(3) receptor-mediated effects in a range of cell types expressing different complements of InsP(3) receptor types. In experiments with permeabilized cells we found that 2-APB could inhibit InsP(3)-induced release of stored Ca(2+), but also that it released Ca(2+), and that the prevalence of these two effects varied between different cell types and did not correlate with the expression of a particular receptor type. These effects of 2-APB reflected an interaction distal to the ligand binding site of InsP(3) receptors, since InsP(3) binding was unaffected by 2-APB. In intact cells, we found only inhibitory effects of 2-APB on Ca(2+) mobilization, and that variation between cell types in the characteristics of this inhibition appeared to be due to differential entry of 2-APB. 2-APB also inhibited InsP(3) receptor ubiquitination and proteasomal degradation, which again was cell type dependent. In total, these data reveal a remarkable degree of variation between cell types in the effects of 2-APB, showing that its usefulness as a specific and universal inhibitor of InsP(3) receptors is limited. However, the ability of 2-APB to inhibit InsP(3) receptor ubiquitination and degradation indicates that 2-APB may block InsP(3)-induced conformational changes in the receptor, resulting in perturbation of multiple regulatory events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379177     DOI: 10.1016/s0143416002001525

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  8 in total

1.  Calcium mobilization via type III inositol 1,4,5-trisphosphate receptors is not altered by PKA-mediated phosphorylation of serines 916, 934, and 1832.

Authors:  M D Soulsby; R J H Wojcikiewicz
Journal:  Cell Calcium       Date:  2007-01-24       Impact factor: 6.817

2.  Caffeine and 2-Aminoethoxydiphenyl Borate (2-APB) Have Different Ability to Inhibit Intracellular Calcium Mobilization in Pancreatic Acinar Cell.

Authors:  Kyung Jin Choi; Kab Sung Kim; Se Hoon Kim; Dong Kwan Kim; Hyung Seo Park
Journal:  Korean J Physiol Pharmacol       Date:  2010-04-30       Impact factor: 2.016

3.  5-Methyltetrahydrofolate and tetrahydrobiopterin can modulate electrotonically mediated endothelium-dependent vascular relaxation.

Authors:  Tudor M Griffith; Andrew T Chaytor; Linda M Bakker; David H Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-02       Impact factor: 11.205

4.  Receptor for activated protein kinase C1 regulates cell proliferation by modulating calcium signaling.

Authors:  Dongmei Cheng; Xiao Zhu; Federica Barchiesi; Delbert G Gillespie; Raghvendra K Dubey; Edwin K Jackson
Journal:  Hypertension       Date:  2011-08-15       Impact factor: 10.190

5.  Sulfhydryl modification induces calcium entry through IP₃-sensitive store-operated pathway in activation-dependent human neutrophils.

Authors:  Leiting Pan; Xian Wu; Dan Zhao; Nason Ma'ani Hessari; Imshik Lee; Xinzheng Zhang; Jingjun Xu
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

6.  Blockage of store-operated Ca2+ entry antagonizes Epstein-Barr virus-promoted angiogenesis by inhibiting Ca2+ signaling-regulated VEGF production in nasopharyngeal carcinoma.

Authors:  Jiaxiang Ye; Junqi Huang; Qian He; Weilin Zhao; Xiaoying Zhou; Zhe Zhang; Yongqiang Li; Jiazhang Wei; Jinyan Zhang
Journal:  Cancer Manag Res       Date:  2018-05-10       Impact factor: 3.989

7.  Histamine activates an intracellular Ca2+ signal in normal human lung fibroblast WI-38 cells.

Authors:  Roberto Berra-Romani; Ajelet Vargaz-Guadarrama; Josué Sánchez-Gómez; Nayeli Coyotl-Santiago; Efraín Hernández-Arambide; José Everardo Avelino-Cruz; Mario García-Carrasco; Monica Savio; Giorgia Pellavio; Umberto Laforenza; Alfredo Lagunas-Martínez; Francesco Moccia
Journal:  Front Cell Dev Biol       Date:  2022-09-02

8.  Interactions of antagonists with subtypes of inositol 1,4,5-trisphosphate (IP3) receptor.

Authors:  Huma Saleem; Stephen C Tovey; Tedeusz F Molinski; Colin W Taylor
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.